Article
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
Journal of the American Heart Association - 26 Jan 2015
Hiltunen Timo P, Donner Kati M, Sarin Antti-Pekka, Saarela Janna, Ripatti Samuli, Chapman Arlene B, Gums John G, Gong Yan, Cooper-DeHoff Rhonda M, Frau Francesca, Glorioso Valeria, Zaninello Roberta, Salvi Erika, Glorioso Nicola, Boerwinkle Eric, Turner Stephen T, Johnson Julie A, Kontula Kimmo K
Abstract excerpt
BACKGROUND: Identification of genetic markers of antihypertensive drug responses could assist in individualization of hypertension treatment. METHODS AND RESULTS: We conducted a genome-wide association study to identify gene loci influencing the responsiveness of 228 male patients to 4 classes of antihypertensive drugs. The Genetics of Drug Responsiveness in Essential Hypertension (GENRES) study is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
